Objectives: Pulmonary hypertension (PH) is composed of a heterogeneous group of disorders marked by increased pulmonary artery resistance leading to right heart failure, with high mortality. Evidence is increasing to propose that inflammation plays a significant role in the pathophysiological mechanism. Increased prevalence of PH in patients with systemic inflammatory diseases is already known. Herein, we sought to evaluate the association between neutrophil to lymphocyte ratio (N/L ratio) and pulmonary arterial hypertension (PAH).
While pulmonary arterial hypertension (PAH) was once regarded mainly as a disease of excessive vasoconstriction, it is now considered to be a vasculopathy in which structural changes caused by excessive vascular cell growth and inflammation play a major role. [2] White blood cell (WBC) count and its subtypes have been studied as inflammatory markers for predicting adverse cardiovascular outcomes. [3, 4] Of these subtypes, the neutrophil to lymphocyte ratio (N/L ratio), was found in several studies to be associated with severity of the disease and prognosis. [5, 6] To the best of our knowledge, N/L ratio has not been studied in patients with PAH. Thus, in this study, we sought to evaluate the association between N/L ratio and PAH.
PATIENTS AND METHODS

Study population
The study group consisted of 25 patients with PAH (16 females, mean age: 37.6±17.7 years), and the control group consisted of 25 healthy volunteers (15 females, mean age: 37.8±12.3 years). The study group included PAH patients who had undergone physical examination, echocardiography, and diagnostic cardiac catheterization. The etiologies were idiopathic in 14 patients and PAH associated with congenital heart disease in 11 patients. All PAH patients were on pulmonary-specific therapy. The control group underwent physical examination and echocardiography. PAH was defined as mean pulmonary arterial pressure (mPAP) ≥25 mmHg and pulmonary capillary wedge pressure ≤15 mmHg at rest detected by cardiac catheterization. [7] Patients were excluded from analysis if they were on warfarin treatment (n=2), or had cancer (n=1), systemic inflammatory disease (n=3), anemia (n=2), active infection (n=2), or left ventricular dysfunction (n=3). The institutional ethics committee approved the study and all patients gave their informed consent.
Biochemical measurements
Venous blood samples were drawn in the morning from the antecubital vein after a fasting period of 12 hours. Total and differential leukocyte counts were measured within 30 minutes of sampling by an automatic blood counter (Abbott Cell-Dyn 3700; Abbott Laboratory, Abbott Park, IL). Glucose, creatinine, and C-reactive protein (CRP) levels were assessed by standard methods.
Statistical analysis
Data were analyzed with the Statistical Package for the Social Sciences (SPSS) software version 16.0 for Windows (SPSS Inc, Chicago, IL). The KolmogorovSmirnov test was used to verify the normality of distribution of continuous variables. Continuous variables were defined as means ± standard deviation; categorical variables were given as percentages. The independent sample t test or the MannWhitney U test was used for the continuous variables and the chisquare test for categorical variables. Spearman test was used for correlation analysis. Statistical significance was defined as p<0.05. Receiver operating characteristic (ROC) curve analysis was used to determine the optimum cutoff levels of N/L ratio in association with PAH. Multivariate logistic regression analysis was performed to assess the independent predictors of PAH. All variables that were found significant in univariate analysis were included in the logistic regression model, and results are shown as an odds ratio (OR) with 95% confidence intervals (CIs).
RESULTS
Baseline demographic, biochemical and hemodynamic parameters of the study and control groups are shown in Table 1 . There were no statistically significant differences between the two groups with respect to age, gender, systolic and diastolic blood pressures, and levels of glucose, creatinine, CRP, hemoglobin, WBC, and platelet count. Mean platelet volume (MPV) and platelet distribution width (PDW) were significantly higher among patients with PAH when compared with the control group (8 Table 2 ). By ROC analysis, a level of N/L ratio ≥1.65 predicted the presence of PAH with 72% sensitivity and 69% specificity (ROC area under curve: 0.767, 95% CI: 0.628-0.906, p=0.002; Fig. 2 ).
DISCUSSION
To our knowledge, N/L ratio has never been studied in PAH, and this is the first study showing the independent relationship between PAH and N/L ratio, which is a simple and reliable indicator of inflammation.
Regardless of the initial trigger, the elevated pulmonary vascular resistance in patients with PAH is primarily caused by endothelial dysfunction, remodeling, vasoconstriction, and thrombosis of small and medium pulmonary arteries.
Endothelial dysfunction is associated with a re- ogy of PAH with elevated levels of many cytokines and chemokines in affected patients. [9, 10] Interleukin (IL)-6 has been linked to the development of pulmonary hypertension in experimental models. [11] Local inflammation and an activated complement system may affect neutrophils and platelets and contribute to plugging in the microvasculature and further vasoconstriction. The resulting vascular remodeling and proliferation cause a chronic elevation in pulmonary vascular resistance, right heart failure and eventually death.
White blood cell subtypes have an important role in modulating the inflammatory response in the PAH pathogenesis. Particularly, lymphocytopenia is a common finding in critical inflammatory states due to the increased lymphocyte apoptosis. [12] CD4+CD25+ cells are regulatory T lymphocytes (Treg) responsible for peripheral immune tolerance and are diminished in autoimmune diseases. There are conflicting data about which lymphocyte subgroup is affected in patients with PAH. Nicolls et al. [13] showed an association between PAH and decreased CD4+ T-cell compartment and a decreased CD4+/CD8+ ratio, similar to the autoimmune or connective tissue disorders. Because of the decreased or ineffective Treg cells, B-cell dysregulation and breakage of natural self-tolerance occur, resulting in increased autoantibodies and immune reaction to self tissues. In another study, Ulrich et al. [14] showed increased CD4+ regulatory and decreased CD8+ cytotoxic T cells in patients with idiopathic PAH (IPAH). They speculated that the increase in Treg cells in the blood of IPAH patients could be attributed to the necessity to suppress any self-reactive T cells for the inhibition of autoimmune disease development and that CD8+ T cells were exhausted, similar to a disease process in chronic viral infections.
Consistent with the literature, we found significantly less lymphocytes in PAH patients compared with controls. As N/L ratio reflects the balance between neutrophil and lymphocyte levels in the body, it is an indicator of systemic inflammation. [4, 15] The present study showed that N/L ratio, a promising marker of inflammation, was increased in PAH. Moreover, a level of N/L ratio ≥1.65 predicted the presence of PAH with 72% sensitivity and 69% specificity. Compared to many other inflammatory markers, N/L ratio is inexpensive, widely available and routinely measured on admission; therefore, it adds no further cost. duction in endothelium-dependent vasodilatation and enhanced vasoconstriction. Adhesion and migration of circulating inflammatory cells occur at sites of endothelial damage, but the cascade of the signaling pathways resulting from such damage and the endothelial dysfunction associated with the inflammatory changes are not well understood in PAH. [8] There is increasing evidence that inflammation and oxidative stress play a role in the pathophysiol- Previous studies have demonstrated the relationship between N/L ratio and coronary artery disease severity, bare metal stent stenosis, and metabolic syndrome, etc. [5, 6, 16] Although N/L ratio was significantly elevated in the PAH group, CRP levels did not differ between the PAH and control groups. This may be due to the exclusion of patients with increased CRP assuming a subclinical infection or the suppression of CRP with specific therapy.
Mean platelet volume and PDW are morphological parameters used in the assessment of platelet reactivity indirectly, and their association with PAH has been investigated in several studies. [17] [18] [19] In patients with PAH, systemic inflammation might cause platelet activation and increase in MPV values by stimulating megakaryocytes. [20] Red cell distribution width quantifies the variability in the size of circulating red blood cells. Inflammation, dysfunctional erythropoiesis, iron deficiency, and oxidative stress are some of possible mechanisms of elevated RDW, which is associated with poor outcomes in various cardiovascular disorders, pulmonary emboli and pulmonary hypertension. [21] [22] [23] [24] In our study, MPV, PDW and RDW tended to increase in the PAH group with respect to the control group. However, only N/L ratio remained statistically significant after multivariate analysis. N/L ratio was well correlated with RDW, supporting the hypothesis that RDW is a marker of underlying inflammation.
Our study has several limitations. This study represented a single center experience conducted on a small patient group due to the rarity of the disease. It provides no information regarding the cause or effect relationship between N/L ratio and PAH. Usage of a single blood sample will not anticipate the persistence of N/L ratio over time.
In conclusion, we showed that N/L ratio was significantly increased in patients with PAH compared with controls. These data may support previous trials reporting that hemostatic abnormalities may be involved directly in the pathogenesis of PAH, but this needs to be confirmed in larger randomized studies with more comprehensive assessment of hemostatic parameters. Understanding the exact role of the inflammatory pathway in the PAH pathogenesis may lead to new therapeutic approaches.
